Related references
Note: Only part of the references are listed.DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics
Felix K. F. Kommoss et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?
Sorsiah Mansor et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2019)
Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas
Paolo Cotzia et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas
Adrian Marino-Enriquez et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations
Lien Hoang et al.
PATHOLOGY (2018)
Novel High-grade Endometrial Stromal Sarcoma A Morphologic Mimicker of Myxoid Leiomyosarcoma
Lien N. Hoang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas
Inga Gruenewald et al.
ONCOTARGET (2016)
Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall
J. Kenneth Schoolmeester et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2015)
Targeted genomic analysis of Mullerian adenosarcoma
Brooke E. Howitt et al.
JOURNAL OF PATHOLOGY (2015)
Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation
Ioannis Panagopoulos et al.
GENES CHROMOSOMES & CANCER (2013)
The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor
Cheng-Han Lee et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
High grade undifferentiated uterine sarcoma: Surgery, treatment, and survival outcomes
Edward J. Tanner et al.
GYNECOLOGIC ONCOLOGY (2012)
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
Isabelle Ray-Coquard et al.
LANCET ONCOLOGY (2012)
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
Cheng-Han Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Liposarcoma Arising in Uterine Lipoleiomyoma: A Report of 3 Cases and Review of the Literature
Anna Greene McDonald et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes -: A comparative analysis of 559 soft tissue neoplasms with genetic data
MBN Binh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization
I Halbwedl et al.
GYNECOLOGIC ONCOLOGY (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors
JI Koontz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
